EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Piperacillin/tazobactam for surgical prophylaxis during pancreatoduodenectomy: meta-analysis

Jayant Kumar iD, Isabella Reccia iD, Adriano Carneiro, Mauro Podda iD, Francesco Virdis, Nikolaos Machairas iD, David Nasralla, Ramesh P Arasaradnam, Kenneth Poon iD, Christopher J Gannon, John J Fung iD, Nagy Habib iD und 1 weitere

BJS Open · 08.05.2024 · 8 (3)

DOI: 10.1093/bjsopen/zrae066 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift BJS Open, online erschienen am 13.06.2024. Verfasst von Jayant Kumar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Antibiotic Prophylaxis, Piperacillin, Tazobactam Drug Combination, Surgical Wound Infection. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatoduodenectomy is associated with an increased incidence of surgical-site infections, often leading to a significant rise in morbidity and mortality. This trend underlines the inadequacy of traditional antibiotic prophylaxis strategies. Hence, the aim of this meta-analysis was to assess the outcomes of antimicrobial prophylaxis, comparing piperacillin/tazobactam with traditional antibiotics.

Methods

Upon registering in PROSPERO, the international prospective register of systematic reviews (CRD42023479100), a systematic search of various databases was conducted over the interval 2000–2023. This inclusive search encompassed a wide range of study types, including prospective and retrospective cohorts and RCTs. The subsequent data analysis was carried out utilizing RevMan 5.4.

Results

A total of eight studies involving 2382 patients who underwent pancreatoduodenectomy and received either piperacillin/tazobactam (1196 patients) or traditional antibiotics (1186 patients) as antibiotic prophylaxis during surgery were included in the meta-analysis. Patients in the piperacillin/tazobactam group had significantly reduced incidences of surgical-site infections (OR 0.43 (95% c.i. 0.30 to 0.62); P < 0.00001) and major surgical complications (Clavien–Dindo grade greater than or equal to III) (OR 0.61 (95% c.i. 0.45 to 0.81); P = 0.0008). Subgroup analysis of surgical-site infections highlighted significantly reduced incidences of superficial surgical-site infections (OR 0.34 (95% c.i. 0.14 to 0.84); P = 0.02) and organ/space surgical-site infections (OR 0.47 (95% c.i. 0.28 to 0.78); P = 0.004) in the piperacillin/tazobactam group. Further, the analysis demonstrated significantly lower incidences of clinically relevant postoperative pancreatic fistulas (grades B and C) (OR 0.67 (95% c.i. 0.53 to 0.83); P = 0.0003) and mortality (OR 0.51 (95% c.i. 0.28 to 0.91); P = 0.02) in the piperacillin/tazobactam group.

Conclusion

Piperacillin/tazobactam as antimicrobial prophylaxis significantly lowers the risk of postoperative surgical-site infections, major surgical complications (complications classified as Clavien–Dindo grade greater than or equal to III), clinically relevant postoperative pancreatic fistulas (grades B and C), and mortality, hence supporting the implementation of piperacillin/tazobactam for surgical prophylaxis in current practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreaticoduodenectomyAntibiotic ProphylaxisPiperacillin, Tazobactam Drug CombinationSurgical Wound InfectionAnti-Bacterial AgentsHumansPiperacillin

Substanzen

Piperacillin, Tazobactam Drug CombinationAnti-Bacterial AgentsPiperacillin

Autor:innen und Institutionen

  • Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK.
  • Department of General Surgery, Memorial Healthcare System, Pembroke Pines, Florida, USA.
  • General Surgery and Oncologic Unit, Policlinico ponte San Pietro, Bergamo, Italy.
  • Department of Surgery, Federal University of Pernambuco, Recife, Brazil.
  • Department of Surgery, Calgiari University Hospital, Calgiari, Italy.
  • Dipartimento DEA-EAS, Ospedale Niguarda Ca' Granda Milano, Milano, Italy.

ORCID-Profile: Jayant Kumar, Isabella Reccia, Mauro Podda, Nikolaos Machairas, Kenneth Poon, John J Fung, Nagy Habib

Zitieren

APA

Kumar, J., Reccia, I., Carneiro, A., Podda, M., Virdis, F., Machairas, N., Nasralla, D., Arasaradnam, R. P., Poon, K., Gannon, C. J., Fung, J. J., Habib, N., & Llaguna, O. (2024). Piperacillin/tazobactam for surgical prophylaxis during pancreatoduodenectomy: meta-analysis. BJS Open, 8(3). https://doi.org/10.1093/bjsopen/zrae066

Vancouver

Kumar J, Reccia I, Carneiro A, Podda M, Virdis F, Machairas N, et al. Piperacillin/tazobactam for surgical prophylaxis during pancreatoduodenectomy: meta-analysis. BJS Open. 2024;8(3). doi:10.1093/bjsopen/zrae066

BibTeX
@article{Kumar2024,
  author = {Kumar, Jayant and Reccia, Isabella and Carneiro, Adriano and Podda, Mauro and Virdis, Francesco and Machairas, Nikolaos and Nasralla, David and Arasaradnam, Ramesh P and Poon, Kenneth and Gannon, Christopher J and Fung, John J and Habib, Nagy and Llaguna, Omar},
  title = {Piperacillin/tazobactam for surgical prophylaxis during pancreatoduodenectomy: meta-analysis},
  journal = {BJS Open},
  year = {2024},
  volume = {8},
  number = {3},
  doi = {10.1093/bjsopen/zrae066}
}
Kostenlos starten →